USE OF ANTI-INTERFERON BETA MONOCLONAL ANTIBODY FOR CASE OF MDA-5 DERMATOMYOSITIS AND ASSOCIATED INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Nasim, Rabab
Palmon, Philip
Nasim, Atif
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1097
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1194A / 1194A
页数：1
相关论文
共 50 条
  • [41] Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis
    Lin, Rachel R.
    Warp, Peyton V.
    Maderal, Andrea D.
    Elman, Scott A.
    JAMA DERMATOLOGY, 2024, 160 (05) : 575 - 577
  • [42] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ASSOCIATION WITH MDA5 ANTIBODY DERMATOMYOSITIS
    Kazmierski, Dan
    Sharma, Nishant
    Wang, Yichen
    Noumi, Bassel
    Ochieng, Pius
    Ejaz, Komal
    CHEST, 2020, 158 (04) : 1140A - 1141A
  • [43] Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease
    Gao, Yujuan
    Zhao, Qi
    Xie, Miaomiao
    Yan, Xin
    Li, Yan
    Zhang, Xin
    Wu, Hongyan
    Dai, Jinghong
    Cao, Min
    Cai, Hourong
    CYTOKINE, 2020, 135
  • [44] Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
    Gono, Takahisa
    Kawaguchi, Yasushi
    Ozeki, Eri
    Ota, Yuko
    Satoh, Takashi
    Kuwana, Masataka
    Hara, Masako
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 223 - 227
  • [45] JUVENILE DERMATOMYOSITIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: WOULD ANTI-MDA5 ANTIBODY DETECTION IMPROVE EARLY DIAGNOSIS AND MANAGEMENT?
    Gallagher, Kathy
    Bale, Peter
    Armon, Kate
    RHEUMATOLOGY, 2018, 57
  • [46] Prognostic Evaluation of Serum Osteopontin in Patients with Anti-MDA5 Antibody-Positive Dermatomyositis Associated Interstitial Lung Disease
    Gao, Y.
    Zhao, Q.
    Xie, M.
    Zhang, X.
    Wu, H.
    Cai, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Serum interleukin-34 levels in dermatomyositis: a potential biomarker for anti-MDA5-antibody-associated interstitial lung disease
    Kuzumi, Ai
    Fukasawa, Takemichi
    Yamashita, Takashi
    Matsuda, Kazuki M.
    Kotani, Hirohito
    Yoshizaki-Ogawa, Asako
    Sato, Shinichi
    Yoshizaki, Ayumi
    RHEUMATOLOGY, 2024,
  • [48] Immunosuppression with triple therapy in a Caucasian female with anti-MDA5 associated dermatomyositis with interstitial lung disease: A case report
    Nguyen, Chilan
    Ta, Brenda
    Nguyen, John Trinh
    Ennis, Samantha
    Parsons, Stephen
    RESPIROLOGY, 2023, 28 : 415 - 416
  • [49] Anti-MDA5 antibody dermatomyositis-associated rapidly progressive interstitial lung disease patient complicated with mixed connective tissue disease: A case report
    Wu, Hua-Man
    Liu, Xian-hong
    Deng, Li-Ping
    Lv, Feng-Yuan
    Zhang, Mei-Xia
    Luo, Jun-Ping
    Tian, Mao-Liang
    Deng, Zhi-Ping
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (06) : 1137 - 1142
  • [50] Anti-MDA5 Antibody Positive Dermatomyositis Is Not Always Associated with Recalcitrant Lung Disease or Mortality
    Soni, Dipekka
    Maniscalco, David
    Veeraraghavan, Srihari
    Cheeley, Justin
    Khosroshahi, Arezou
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345